skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total Assignments: 3
Patent #:
NONE
Issue Dt:
Application #:
10015534
Filing Dt:
12/13/2001
Publication #:
Pub Dt:
05/08/2003
Inventors:
Burton G. Christensen, John H. Griffin, Thomas E. Jenkins, J. Kevin Judice
Title:
Methods for identifying novel multimeric agents that modulate receptors
Assignment: 1
Reel/Frame:
012573/0545Recorded: 04/10/2002Pages: 3
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
Exec Dt:
12/12/2001
Exec Dt:
12/12/2001
Exec Dt:
12/12/2001
Exec Dt:
12/12/2001
Assignee:
LEGAL DEPARTMENT
901 GATEWAY BOULEVARD
SOUTH SAN FRANCISCO, CALIFORNIA 94080
Correspondent:
ADVANCED MEDICINE, INC.
DAVID E. BOONE
901 GATEWAY BOULEVARD
SOUTH SAN FRANCISCO, CA 94080
Assignment: 2
Reel/Frame:
012954/0429Recorded: 06/03/2002Pages: 8
Conveyance:
MERGER (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
04/03/2002
Assignee:
901 GATEWAY BOULEVARD
SOUTH SAN FRANCISCO, CALIFORNIA 94080
Correspondent:
THERAVANCE, INC.
DAVID E. BOONE
901 GATEWAY BOULEVARD
SOUTH SAN FRANCISCO CA 94080
Assignment: 3
Reel/Frame:
033180/0093Recorded: 06/12/2014Pages: 5
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
06/01/2014
Assignee:
901 GATEWAY BOULEVARD
SOUTH SAN FRANCISCO, CALIFORNIA 94080
Correspondent:
JEFFREY A. HAGENAH
PATENT DEPARTMENT
THERAVANCE BIOPHARMA US, INC.
901 GATEWAY BOULEVARD
SOUTH SAN FRANCISCO, CALIFORNIA 94080

Search Results as of: 05/07/2024 09:04 AM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT